Schrödinger to Announce Fourth Quarter and Full-Year 2021 Financial Results on February 24

Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will release its fourth quarter and full year 2021 financial results on February 24, 2022, after market close. A conference call will take place at 4:30 p.m. ET. Interested parties can access the live webcast on Schrödinger’s website. The company focuses on a physics-based software platform that enhances therapeutic and materials discovery, used by various organizations globally. With over 500 employees and clients in more than 70 countries, Schrödinger aims to lower costs and speed up drug development.

Positive

• Transformative physics-based software platform for faster drug and material discovery.
• Engaged with clients and collaborators in over 70 countries.
• Strong emphasis on addressing unmet medical needs.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. To participate in the live call, please dial (833) 727-9520 (domestic) or +1 (830) 213-7697 (international) and refer to conference ID 3169814. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.

About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 500 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Twitter, or visit our blog, Extrapolations.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005020/en/

Jaren Madden

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264

Source: Schrödinger

FAQ

When will Schrödinger report its 2021 financial results?

Schrödinger will report its fourth quarter and full year 2021 financial results on February 24, 2022, after market close.

What time is the conference call for Schrödinger's financial results?

The conference call is scheduled for 4:30 p.m. ET on February 24, 2022.

How can I access Schrödinger's financial results webcast?

The webcast can be accessed on Schrödinger’s website under 'News & Events' in the investors section.

What is the focus of Schrödinger's software platform?

Schrödinger's software platform focuses on transforming the discovery of therapeutics and materials, enabling faster and cost-effective development.